Page last updated: 2024-08-25

doripenem and Bacterial Pneumonia

doripenem has been researched along with Bacterial Pneumonia in 20 studies

Research

Studies (20)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	5 (25.00)	29.6817
2010's	14 (70.00)	24.3611
2020's	1 (5.00)	2.80

Authors

Authors	Studies
Fukuda, H; Hashimoto, T; Hashinaga, K; Hayashidani, H; Nureki, SI; Sakamoto, T; Shigemitsu, O; Takenaka, R	1
Chida, K; Harada, M; Inui, N; Matsuo, Y; Nakamura, Y; Suda, T; Wajima, T	1
Ikawa, K; Ishihara, N; Isobe, T; Karino, F; Miura, K; Morikawa, N; Naora, K; Nishimura, N; Tamaki, H	1
Barauskas, V; Bradley, JS; Cannavino, CR; Castaneda-Ruiz, B; Cirillo, I; Emeryk, A; Go, O; Redman, R; Senatorova, G	1
Akata, K; Ishimoto, H; Kawanami, T; Kido, T; Mukae, H; Naito, K; Nishida, C; Noguchi, S; Sakamoto, N; Yamasaki, K; Yatera, K	1
Badal, RE; Biedenbach, DJ; Giao, PT; Hung Van, P; Phuong, DM; Su Minh Tuyet, N; Thi Thanh Nga, T; Vu Trung, N	1
Friedland, I; Kaniga, K; Ketter, N; Lee, M; Lobo, SM; Niederman, M; Prokocimer, P; Réa-Neto, A; Schroeder, E	1
Micek, ST; Neuner, EA; Ritchie, DJ	1
Depestel, DD; Paterson, DL	1
Guery, BP	1
Lin, R; Nandy, P; Samtani, MN	1
Elborn, JS; Parkins, MD	1
Boutoille, D; Bretonnière, C; Caillon, J; Guitton, C; Jacqueline, C; Le Mabecque, V; Miégeville, AF; Potel, G; Villers, D	1
Apisarnthanarak, A; Mundy, LM	1
Abbanat, D; Barron, A; Bunting, RA; Fernandez, J; Flamm, RK; Hall, L; Hilliard, JJ; Lynch, AS; Melton, JL; Ward, CK	1
Akalın, H; Akova, M; Arman, D; Aygen, B; Başaran, S; Bayramoğlu, G; Dizbay, M; Dokuzoğuz, B; Eraksoy, H; Esener, H; Hasçelik, G; Köksal, I; Korten, V; Oğünç, D; Sınırtaş, M; Söyletir, G; Sümerkan, B; Tünger, A; Ulusoy, S; Yalçın, AN	1
Boutoille, D; Bretonnière, C; Caillon, J; Desessard, C; Guitton, C; Jacqueline, C; Le Mabecque, V; Miégeville, AF; Potel, G; Villers, D	1
Lipman, J; Roberts, JA	1
van der Meer, YG; van Zanten, AR	1
Joseph, J; Rodvold, KA	1

Reviews

6 review(s) available for doripenem and Bacterial Pneumonia

Article	Year
Septic shock due to Yersinia pseudotuberculosis infection in an adult immunocompetent patient: a case report and literature review. BMC infectious diseases, 2021, Jan-07, Volume: 21, Issue:1 Topics: Adult; Anti-Bacterial Agents; Azithromycin; Bacteremia; Blood Culture; Cefmetazole; Ceftriaxone; Doripenem; Fever; Humans; Immunocompetence; Male; Pneumonia, Bacterial; Shock, Septic; Yersinia pseudotuberculosis; Yersinia pseudotuberculosis Infections	2021
New antibiotics for healthcare-associated pneumonia. Seminars in respiratory and critical care medicine, 2009, Volume: 30, Issue:1 Topics: Aminoglycosides; Anti-Bacterial Agents; Carbapenems; Ceftaroline; Cephalosporins; Cross Infection; Doripenem; Glycopeptides; Lipoglycopeptides; Methicillin-Resistant Staphylococcus aureus; Pneumonia, Bacterial; Pseudomonas Infections; Pyrimidines; Staphylococcal Infections; Teicoplanin	2009
Doripenem. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2009, Jul-15, Volume: 49, Issue:2 Topics: Carbapenems; Doripenem; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Peritonitis; Pneumonia, Bacterial; Seizures; Urinary Tract Infections	2009
[Doripenem: need for a new carbapenem]. Medecine et maladies infectieuses, 2009, Volume: 39, Issue:12 Topics: Animals; Anti-Bacterial Agents; Bacterial Infections; Burkholderia cepacia; Carbapenems; Clinical Trials as Topic; Cross Infection; Doripenem; Drug Evaluation, Preclinical; Drug Resistance, Multiple, Bacterial; Humans; Nervous System Diseases; Peritonitis; Pneumonia, Bacterial; Pseudomonas aeruginosa; Urinary Tract Infections	2009
Newer antibacterial agents and their potential role in cystic fibrosis pulmonary exacerbation management. The Journal of antimicrobial chemotherapy, 2010, Volume: 65, Issue:9 Topics: Achromobacter denitrificans; Anti-Bacterial Agents; Carbapenems; Cephalosporins; Cystic Fibrosis; Doripenem; Humans; Minocycline; Pneumonia, Bacterial; Pseudomonas aeruginosa; Staphylococcus aureus; Stenotrophomonas maltophilia; Tigecycline	2010
The role of carbapenems in the treatment of severe nosocomial respiratory tract infections. Expert opinion on pharmacotherapy, 2008, Volume: 9, Issue:4 Topics: Anti-Bacterial Agents; beta-Lactams; Carbapenems; Cross Infection; Doripenem; Drug Administration Schedule; Drug Resistance, Multiple, Bacterial; Ertapenem; Humans; Imipenem; Meropenem; Patient Selection; Pneumonia, Bacterial; Respiratory Tract Infections; Severity of Illness Index; Thienamycins; Treatment Outcome	2008

Trials

4 trial(s) available for doripenem and Bacterial Pneumonia

Article	Year
Safety and Tolerability of Doripenem in Hospitalized Children With Complicated Intra-Abdominal Infection, Complicated Urinary Tract Infections and Pneumonia. The Pediatric infectious disease journal, 2015, Volume: 34, Issue:11 Topics: Adolescent; Anti-Bacterial Agents; Carbapenems; Child; Child, Preschool; Doripenem; Hospitalization; Humans; Infant; Intraabdominal Infections; Pneumonia, Bacterial; Treatment Outcome; Urinary Tract Infections	2015
Efficacy and safety of doripenem versus piperacillin/tazobactam in nosocomial pneumonia: a randomized, open-label, multicenter study. Current medical research and opinion, 2008, Volume: 24, Issue:7 Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteria; Carbapenems; Cross Infection; Doripenem; Female; Humans; Male; Middle Aged; Penicillanic Acid; Piperacillin; Pneumonia, Bacterial; Prospective Studies; Tazobactam; Treatment Outcome	2008
Population pharmacokinetics of doripenem based on data from phase 1 studies with healthy volunteers and phase 2 and 3 studies with critically ill patients. Antimicrobial agents and chemotherapy, 2010, Volume: 54, Issue:6 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacterial Infections; Bayes Theorem; Carbapenems; Creatinine; Critical Illness; Cross Infection; Doripenem; Female; Humans; Kidney; Male; Metabolic Clearance Rate; Middle Aged; Models, Biological; Nonlinear Dynamics; Pneumonia, Bacterial; Pyelonephritis; Renal Insufficiency; Urinary Tract Infections; Young Adult	2010
Optimal doripenem dosing simulations in critically ill nosocomial pneumonia patients with obesity, augmented renal clearance, and decreased bacterial susceptibility. Critical care medicine, 2013, Volume: 41, Issue:2 Topics: Anti-Bacterial Agents; Carbapenems; Creatinine; Critical Illness; Cross Infection; Doripenem; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Intensive Care Units; Male; Middle Aged; Monte Carlo Method; Obesity; Pneumonia, Bacterial	2013

Other Studies

10 other study(ies) available for doripenem and Bacterial Pneumonia

Article	Year
Pharmacokinetic analysis of doripenem in elderly patients with nosocomial pneumonia. International journal of antimicrobial agents, 2013, Volume: 42, Issue:2 Topics: Administration, Intravenous; Aged; Aged, 80 and over; Anti-Bacterial Agents; Carbapenems; Chromatography, Liquid; Cross Infection; Doripenem; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Models, Statistical; Plasma; Pneumonia, Bacterial; Tandem Mass Spectrometry; Time Factors	2013
Evaluation of a pharmacokineticpharmacodynamic approach using software to optimize the carbapenem antibiotic regimen. International journal of clinical pharmacology and therapeutics, 2015, Volume: 53, Issue:6 Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Carbapenems; Computer Simulation; Doripenem; Drug Administration Schedule; Drug Dosage Calculations; Drug Monitoring; Drug Therapy, Computer-Assisted; Female; Humans; Kidney; Male; Meropenem; Microbial Sensitivity Tests; Middle Aged; Models, Biological; Monte Carlo Method; Pneumonia, Bacterial; Prospective Studies; Software; Thienamycins; Treatment Outcome	2015
Clinical efficacy and safety of high-dose doripenem in Japanese patients with pneumonia. Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 2016, Volume: 22, Issue:3 Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Carbapenems; Doripenem; Female; Humans; Japan; Male; Pneumonia, Bacterial; Prospective Studies; Sputum; Treatment Outcome	2016
Antimicrobial-resistant Pseudomonas aeruginosa and Acinetobacter baumannii From Patients With Hospital-acquired or Ventilator-associated Pneumonia in Vietnam. Clinical therapeutics, 2016, Volume: 38, Issue:9 Topics: Acinetobacter baumannii; Amikacin; Anti-Bacterial Agents; beta-Lactamase Inhibitors; beta-Lactams; Carbapenems; Cefepime; Cephalosporins; Cross Infection; Doripenem; Drug Resistance, Multiple, Bacterial; Fluoroquinolones; Gentamicins; Humans; Longitudinal Studies; Microbial Sensitivity Tests; Minocycline; Pneumonia, Bacterial; Pneumonia, Ventilator-Associated; Pseudomonas aeruginosa; Tigecycline; Vietnam	2016
Efficacy of doripenem in the treatment of Pseudomonas aeruginosa experimental pneumonia versus imipenem and meropenem. The Journal of antimicrobial chemotherapy, 2010, Volume: 65, Issue:11 Topics: Animals; Anti-Bacterial Agents; Bacterial Load; Blood; Carbapenems; Disease Models, Animal; Doripenem; Female; Imipenem; Infusions, Intravenous; Lung; Meropenem; Plasma; Pneumonia, Bacterial; Pseudomonas aeruginosa; Pseudomonas Infections; Rabbits; Spleen; Thienamycins; Treatment Outcome	2010
Use of high-dose 4-hour infusion of doripenem, in combination with fosfomycin, for treatment of carbapenem-resistant Pseudomonas aeruginosa pneumonia. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2010, Dec-01, Volume: 51, Issue:11 Topics: Aged; Anti-Bacterial Agents; beta-Lactam Resistance; Carbapenems; Doripenem; Drug Therapy, Combination; Female; Fosfomycin; Humans; Infusions, Intravenous; Male; Middle Aged; Pneumonia, Bacterial; Pseudomonas aeruginosa	2010
Comparative effects of carbapenems on bacterial load and host immune response in a Klebsiella pneumoniae murine pneumonia model. Antimicrobial agents and chemotherapy, 2011, Volume: 55, Issue:2 Topics: Animals; Anti-Bacterial Agents; Bacterial Load; beta-Lactamases; Carbapenems; Cytokines; Disease Models, Animal; Doripenem; Female; Humans; Imipenem; Klebsiella Infections; Klebsiella pneumoniae; Lung; Meropenem; Mice; Mice, Inbred C3H; Microbial Sensitivity Tests; Pneumonia, Bacterial; Thienamycins; Treatment Outcome	2011
[Comparative evaluation of in vitro activities of carbapenems against gram-negative pathogens: Turkish data of COMPACT study]. Mikrobiyoloji bulteni, 2011, Volume: 45, Issue:2 Topics: Anti-Bacterial Agents; Bacteremia; Carbapenems; Cross Infection; Doripenem; Drug Resistance, Bacterial; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Imipenem; Intensive Care Units; Meropenem; Microbial Sensitivity Tests; Pneumonia, Bacterial; Thienamycins; Turkey	2011
Evaluation of doripenem in an experimental model of resistant Pseudomonas aeruginosa pneumonia. The Journal of antimicrobial chemotherapy, 2012, Volume: 67, Issue:3 Topics: Animals; Anti-Bacterial Agents; Bacterial Load; beta-Lactam Resistance; Carbapenems; Colony Count, Microbial; Disease Models, Animal; Doripenem; Humans; Imipenem; Lung; Meropenem; Pneumonia, Bacterial; Pseudomonas aeruginosa; Pseudomonas Infections; Rabbits; Thienamycins; Treatment Outcome	2012
Prolonged infusion of carbapenems in critically ill patients: time to extend our practice. Critical care medicine, 2013, Volume: 41, Issue:2 Topics: Anti-Bacterial Agents; Carbapenems; Creatinine; Doripenem; Female; Humans; Male; Obesity; Pneumonia, Bacterial	2013

chemdatabank.com